Key Details
Symbol (NSE): ZENSARTECH
Corporate Action: Scheme of Amalgamation
Record Date: Not Specified
Nature of Scheme: Amalgamation of wholly-owned subsidiary into holding company
Entities Involved:
- Transferor/Amalgamating Company: M3bi India Private Limited
- Transferee/Amalgamated Company: Zensar Technologies Limited
Demerged Company: Not Applicable (Amalgamation)
Resulting Company: Zensar Technologies Limited (after absorbing M3BI)
Share Entitlement Ratio: No share issuance. The shares held by Zensar Technologies Limited in M3BI India Private Limited will stand cancelled upon the scheme becoming effective with no consideration issued.
Implied Capital Structure Impact: No change in the equity shareholding pattern of Zensar Technologies Limited pursuant to the Scheme as the Amalgamating Company is a wholly owned subsidiary.
Post-Allotment Listing Plan: M3BI India Private Limited will be dissolved without winding up. No separate listing involved.
Regulatory and Approval Status: The Scheme is subject to sanction of National Company Law Tribunal (NCLT) and receipt of necessary approvals from other regulatory/statutory authorities as required. The Company is exempt from obtaining observation letter/no objection letter from stock exchanges before filing with NCLT under Regulation 37(6) of SEBI Listing Regulations.
Effective Date: Not Specified
Financial Rationale: To achieve greater business synergies and higher operational efficiencies. It will also lead to effective management, unified control of operations and efficient utilization of resources and customer relationships.
Impact on Shareholders: No change in the equity shareholding pattern of Zensar Technologies Limited. The amalgamation is between a holding company and its wholly-owned subsidiary, hence no dilution or ownership restructuring.
Financial Metrics (as on September 30, 2026, standalone basis)
(In INR Million)
| Entity Name | Net Worth | Turnover* |
| Zensar Technologies Limited | 35,315 | 15,729 |
| M3bi India Private Limited | 1,130 | 1,235 |
*For six months ended September 30, 2026
Regulatory Compliance Notes
- The transaction qualifies as related party transaction but is exempt from Section 188 of Companies Act, 2013 per MCA Circular No. 30/2014 dated July 17, 2014
- Exempt from related party transaction provisions under Regulation 23(5)(b) of SEBI Listing Regulations
- Exempt from requirements of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated 20th June 2023
Timeline
Board meeting held on October 28, 2026, commencing at 06:30 PM (IST) and concluding at 10:02 PM (IST)